NOTRELOAD AI
  • NOTRELOAD AI
  • myNOTRELOAD
  • One-Time License
  • Invest ↗
  • XY Feed
  • Push Notifications
Sign in Subscribe

Traws Pharma Falls After FDA Puts Flu Drug Application on Clinical Hold

Traws Pharma stock dropped 23% today after the FDA placed a clinical hold on its monthly flu prevention pill due to mutagenicity concerns. Positive COVID drug results couldn’t offset the news.

Traws Pharma Falls After FDA Puts Flu Drug Application on Clinical Hold
Credit: Traws Pharma
Already have an account? Sign in.
02/19/2026 · 9:51 AM
TRAW
/ Don’t stop at just one post.

Related↓

Traws Pharma Puts Phase 2 Influenza Trial on Hold After UK Regulator Feedback
06/15/2026 · 7:20 AM

Traws Pharma Puts Phase 2 Influenza Trial on Hold After UK Regulator Feedback

Traws Pharma shares fell after delaying its Phase 2 human influenza challenge study due to negative feedback from the UK’s MHRA. The company is now advancing backup flu antiviral candidates.

/ Subscriber only
/ Read more

Feed↓

Wall Street Initiates Coverage of Lycia Therapeutics with Buy Ratings on Extracellular Degrader Platform
11/17/2026 · 12:43 PM

Wall Street Initiates Coverage of Lycia Therapeutics with Buy Ratings on Extracellular Degrader Platform

Multiple analysts initiated Buy ratings on Lycia Therapeutics, pointing to its differentiated LYTAC platform and potential in the growing food allergy market.

/ Subscriber only
TPG Close to Taking Payments Platform Bill Holdings Private
11/17/2026 · 12:07 PM

TPG Close to Taking Payments Platform Bill Holdings Private

The payments software firm has faced activist pressure.

/ Subscriber only
Jensen Huang Says He Is Open to Returning as Nvidia CEO
Featured/ 11/17/2026 · 11:41 AM

Jensen Huang Says He Is Open to Returning as Nvidia CEO

In his first statement since resigning, former Nvidia CEO Jensen Huang expressed regret and said he would return if the board wants him.

/ Subscriber only
Explore
  • NOTRELOAD AI
  • myNOTRELOAD
  • One-Time License
  • Invest ↗
  • XY Feed
  • Push Notifications
More
  • Sign up
  • Sign in
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Terms/Privacy
  • UP↑
Get alerts

Be the first to know when deals break, stocks move, or biotech headlines hit.

Email address Subscribe
DON'T FALL BEHIND. ©2026
For informational purposes only. Not financial advice.
NOTRELOAD AI